adrenocortical carcinoma

(redirected from Adrenal carcinoma)

adrenocortical carcinoma

Oncology A rare–≤ 2 in 106/yr tumor of the adrenal cortex; average age 46; ♂:♀ ratio 1:2.5 Clinical ± 70% of Pts with AC have endocrine symptoms due to excess secretion of glucocorticoids and/or androgens, less commonly due to excess mineralocorticoids or estrogens Management Surgical resection, mitotane. See Mitotane.
Adrenocortical cancer
Stage I
CA < 5 cms; no spread to periadrenal tissues
Stage II
CA > 5 cms; no spread to periadrenal tissues
Stage III
CA spread to periadrenal tissues or lymph nodes
Stage IV
CA spread to regional tissues or organs, to lymph nodes around adrenal cortex, or metastasized
.
References in periodicals archive ?
Adrenal carcinoma with intravenous extension into the tricuspid valvular plane in a patient with patent foramen ovale.
The differential diagnoses include neuroblastoma, ganglioneuroblastoma, adrenal hemorrhage, granulomatous disease/infection, lymphoma, and adrenal carcinoma.
Here, it is described the clinico-pathological findings of two cows with IO, due to an ovarian teratoma in one and a metastatic adrenal carcinoma in the other.
The patient had pre-operative fine needle biopsy suggestive of RCC without any clinical sign of adrenal carcinoma.
Primary adrenal carcinoma (ACC) is a rare, aggressive malignancy arising from the adrenal cortex.
Primary adrenal carcinoma is also rare, with an estimated incidence of 2 cases per one million in the general population.
Adrenal Carcinoma (Oncology)--eMedicine: Updated: Dec 4, 2009.
Even though many aggressive tumors such as adrenal carcinoma share some of these findings, diagnosis of GN should be considered in the presence of all or most of these findings (3).
Adrenal carcinoma is uncommon and accounts for approximately 0.
Biochemical Markers in a 64-Year-Old Woman with Metastatic Adrenal Carcinoma Laboratory Patient Established Measure Value Normal Values Potassium 2.
Kendra's gastrointestinal exam was normal without masses and was confirmed by ultrasound, which ruled out adrenal carcinoma.
The panel chose to focus on what is known: that the overall risk of an incidentally found mass being a primary adrenal carcinoma appears to be about 0.